patient
|
3 |
Age
|
43 |
Gender
|
male |
Origin
|
Germany |
Genotype
|
A |
PC_CP mutation
|
wt |
Weight(kg)
|
90 |
Duration of Pretreatment with Lamivudine (mo)
|
29 |
HBeAg Status at Baseline ADV
|
positive |
HBV DNA at Baseline ADV (log10 copies/mL)
|
9.52 |
Duration of ADV Therapy (mo)
|
16 |
HBV DNA at Baseline TDF (log10 copies/mL)
|
6.3 |